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The aim of this study was to conduct a systematic review of the literature regarding the prevalence of sexual
dysfunction in patients with cardiovascular diseases. An article search of the ISI Web of Science and PubMed
databases using the search terms "sexual dysfunction’’, ‘‘cardiovascular diseases’’, ‘‘coronary artery disease",
‘‘myocardial infarct" and ‘‘prevalence’’ was performed.
In total, 893 references were found. Non-English-language and repeated references were excluded. After an
abstract analysis, 91 references were included for full-text reading, and 24 articles that evaluated sexual
function using validated instruments were selected for this review. This research was conducted in October
2012, and no time restrictions were placed on any of the database searches. Reviews and theoretical articles
were excluded; only clinical trials and epidemiological studies were selected for this review.
The studies were mostly cross-sectional, observational and case-control in nature; other studies used
prospective cohort or randomized clinical designs. In women, all domains of sexual function (desire, arousal,
vaginal lubrication, orgasm, sexual dissatisfaction and pain) were affected. The domains prevalent in men
included erectile dysfunction and premature ejaculation and orgasm.
Sexual dysfunction was related to the severity of cardiovascular disease. When they resumed sexual activity,
patients with heart disease reported significant difficulty, including a lack of interest in sex, sexual
dissatisfaction and a decrease in the frequency of sexual activity.
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& INTRODUCTION
According to the DSM-IV, sexual dysfunction (SD) is
characterized by a disturbance in the sexual response cycle
or pain associated with sexual intercourse. SD is listed as
sexual desire disorder, female sexual arousal dysfunction,
male erectile dysfunction (ED), female and male orgasm
dysfunction, premature ejaculation and sexual pain (vagi-
nismus and dyspareunia). Sexual disorders are often
comorbid, and multiple dysfunctions harm other phases of
the sexual cycle (1).
These sexual disorders might have an organic etiology,
psychogenic etiology or both underlying the medical
conditions (1-2). Cardiovascular diseases (CVDs) represent
multiple risk and predictive factors for SDs. A systemic
vascular condition, which affects arteries throughout the
body, also affects the vaginal and penile arteries (the blood
supply of the genital organs); consequently, patients with
heart diseases show symptoms of SD (3-7).
Psychological factors due to cardiovascular events greatly
affect patients’ sexual lives, which contributes to the
incidence of SD. Patients who return to sexual activity can
present mood instability, and many report a certain degree
of difficulty with sexual intercourse and a fear of sudden
death during sex due to increased cardiorespiratory
frequency, blood pressure and physical exertion (8-10).
The present study systematically reviewed the literature
on the prevalence of SD in patients with CVDs.
& METHODOLOGY
The ISI Web of Knowledge and PubMed databases were
searched using the terms "sexual dysfunction’’, ‘‘cardiovas-
cular diseases’’, ‘‘coronary artery disease", ‘‘myocardial
infarct" and ‘‘prevalence’’.
This study was conducted in October 2012, without any
temporal restrictions placed on the searches. To meet the
inclusion criteria, only complete, original articles written in
Copyright  2013 CLINICS – This is an Open Access article distributed under
the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-
commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.
No potential conflict of interest was reported.
DOI: 10.6061/clinics/2013(11)13
REVIEW
1462
English that assessed sexual function using validated
instruments were selected. Articles were excluded if they
were written in languages other than English, were
duplicates or review articles or were irrelevant to the topic.
& RESULTS
Searches of PubMed and the ISI Web of Knowledge
identified 468 and 425 references, respectively, for a total of
893 references. Of these articles, 151 were excluded because
they were duplicates, and 93 were removed because they
were written in languages other than English. Thus, 649
references remained for an abstract analysis. After this
analysis, 115 articles were retrieved for full-text reading. The
eligibility criteria for the selected articles were based on the
themes of the search terms. Thus, 91 articles were deleted,
and 24 articles remained for the literature review. Figure 1
shows a flowchart of this process.
All of the 24 articles selected using the inclusion criteria
evaluated the prevalence of SD in patients with CVDs.
The results are presented according to the studies’
methodologies: 18 cross-sectional, observational studies; 3
case-control studies; 2 prospective studies; and 1 rando-
mized clinical trial (Table 1).
Prospective Cohort Studies
In 1980, Wabrek et al. (11) conducted the first study
related to the sexual functioning of men (131 in total)
between the ages of 31 and 86 years six weeks after their
first myocardial infarction (MI). The researchers’ data
indicated that ED was present in 64% of men, that 28%
showed decreased sexual frequency and that 8% presented
with premature ejaculation. In 2012, Lindau et al. (34)
investigated the loss of sexual activity one year after MI.
Their study recruited 1,274 men and 605 women with mean
ages of 61.1 and 58.6 years, respectively, for a total of 1,879
patients. A decreased frequency of sexual activity was
reported by 48% of men and 59% of women, and 11% of
men and 13% of women did not return to sexual activity.
This study concluded that the absence of sexual desire
contributed to the reduction in patient sexual activity.
Cross-Sectional, Observational Studies
In 1996, Jaarsma et al. (12) investigated the sexual
functioning of 62 men and 18 women with heart failure
and average ages of 52.8 and 53.4 years, respectively, for a
total of 80 patients. Forty-five patients (75%) reported a lack
of sexual interest, 47 (76%) showed a marked decrease in
sexual activity, 30 (32%) reported not engaging in sexual
activity, 15 (24%) showed a decrease in sexual frequency, 12
(19%) reported sexual dissatisfaction, and 62 reported
minimal or no changes. In 1997, Greenstein et al. (15)
examined the effect of coronary artery disease (CAD) on the
erectile function of 40 men with documented angiographies
and an average age of 56 years. The results revealed that 15
(37.5%) men had an occlusion of one coronary vessel. These
men were more likely to have (p,0.04) and maintain
(p,0.007) an erection than the 8 men with two occluded
coronary vessels (20%) and the 17 men with three occluded
coronary vessels (42.5%). Age, diabetes and hypertension
negatively affected the erection quality (p,0.05) of all
patients. In 1998, Drory et al. (15) examined whether
demographics and psychological and medical variables
affected the indicators of satisfaction and sexual frequency
in 276 men between the ages of 30 and 65 years after their
first MI. The results revealed that a change in sexual
frequency (32%) was associated with age and education.
Age was the only variable that explained variation in patient
sexual satisfaction (23%). Medical and psychological vari-
ables (i.e., diabetes and depression) were non-significant
contributors.
In 2000, Drory et al. (17) examined gender differences in
sexual activity and their relationship with demographic
and medical variables six months after the first MI. The
participants included 462 men and 51 women with average
ages of 52 and 56 years, respectively, for a total of 513
patients. The results revealed that women reported reduc-
tions in sexual frequency (p= 0.77) and sexual satisfaction
(p= 0.42). Men showed decreased sexual activity (p= 0.45)
and sexual satisfaction (p= 0.42). The medical and demo-
graphic variables did not predict the sexual activity of either
sex. In 2001, Burkhart et al. (18) investigated ED associated
with cardiovascular complications in patients with hyper-
tension. This sample was composed of 104 men aged 18-75
years. The results revealed that ED (70.6%) was correlated
with cardiovascular complications (p,0.05). Of the 22 men
with ED, 30.6% showed symptoms of depression. The study
concluded that ED is a marker of cardiovascular complica-
tions in patients with hypertension. In 2003, Montorsi et al.
(19) evaluated the prevalence of ED and its chronological
and etiological associations in 300 men with angiography-
documented CAD (average age = 62 years). The dataFigure 1 - Study selection.
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Table 1 - Published studies regarding the prevalence of sexual dysfunction in patients with cardiovascular diseases.
Authors and year Population Instrument/Measure Summary
Wabrek et al., 1980 (11) Male IIEF (35) Six weeks after their first MI, 64% of patients
presented with ED, 28% presented with decreased
sexual frequency, and 8% presented with
premature ejaculation.
Jaarsma et al., 1996 (12) Male and Female SAS and PAIS (36) Heart failure resulted in significant changes in
sexual desire and the frequency of sexual activity.
Greenstein et al., 1997 (13) Male Questionnaire by O’Leary
(37)
The severity of CAD decreased the frequency of
erections.
Abramov LA et al., 1997 (14) Female Student’s t-test and X2
contingency (38)
High prevalence of reduced desire and sexual
dissatisfaction among 50 patients (65%) after MI
compared with 20 (24%) controls.
Drory et al., 1998 (15) Male QSF (39) After MI, patients showed changes in sexual
frequency (32%) associated with age and
education. For 23%, sexual dissatisfaction was
correlated with age.
Hultgren et al., 1999 (16) Female FSFI (40) Patients with AIOD experienced negative effects on
sexual arousal, orgasm and vulvar sensitivity.
Drory et al., 2000 (17) Male and Female QSF (39) The frequency of and satisfaction with sexual
activity were similarly reduced for both sexes.
Burchardt et al., 2001 (18) Male IIEF (35) and CESD (41) ED was considered as a marker of cardiovascular
complications (p,0.05) in 70 patients (70.6%) with
hypertension. In total, 22 (30.6%) patients with ED
showed signs of depression.
Montorsi et al., 2003 (19) Male IIEF (35) ED occurred 38.8 months before the advent of CAD
in 99 patients (67%) men. ED was evident before
heart disease in 70% of all cases.
Vacanti et al., 2005 (20) Male IIEF (35) and HADS (42) After MI, patients showed an incidence of 40.5% of
ED and depressive symptoms.
Addis et al., 2005 (21) Female Logistic regression A total of 1,091 patients had SD, of whom 140
(13%) complained of one sexual problem, and 570
(52%) complained of two or more.
Shi et al., 2006 (22) Male IIEF (35) Patients with CAD in the acute (p.0.05) and chronic
(p,0.05) phases.
Kazemi-Saleh et al., 2007 (23) Male HADS (42) and RSS (43) Twenty-nine patients (33.3%) showed sexual fear,
depressive symptoms and a decreased frequency of
sexual activity.
Eyada et al., 2007 (24) Female ASEX (44) Pectoral angina had a negative effect on the
frequency and sexual satisfaction of patients.
Kaya et al., 2007 (25) Female FSFI (40) All FSFI domain scores, except satisfaction, were
lower in patients with CAD compared with healthy
individuals (p,0.05).
Lunelli et al., 2008 (26) Male and Female Mann-Whitney tests (26) In total, 60% of patients had doubts about their
return to sexual activity, and 44% had reduced their
sexual frequency.
Cook et al., 2008 (27) Male t-tests with Bonferroni
correction (45)
Patients using BBs reported three times more ED
(p=0.045).
Kazemi et al., 2008 (28) Male and Female RSS (46) and HADS (42) Male and female patients with CAD and symptoms
of depression had sex less frequently. Male
depression was correlated with the couple’s fear of
sexual intercourse.
Schwarz et al., 2008 (29) Male and Female IIEF (35) and FSFI (40) Male and female patients showed a high prevalence
of SD.
Hoffman et al., 2010 (30) Male ASEX (44) ED was associated with greater CVD risk and
impaired vascular endothelial function in depressed
men.
Lemogne et al., 2010 (31) Male IIEF-5 (47), BDI-13 (48),
STAI (49) and DS-14 (50)
The prevalence of ED (57.6%) was negatively
associated with age and depressed mood.
Kriston et al., 2010 (32) Male and Female IIEF (35), FSFI (40)
and HADS (42)
ED was found in 20.3% of men, and SD was found in
43.1% of women. Symptoms of moderate
depression were found in 16.5% and 14.4% of men
and women, respectively.
Foruzan-Nia et al., 2011 (33) Male IIEF (35) SD was prevalent one year after MI.
Lindau et al., 2012 (34) Male and Female PHQ-9 (51) and
F-12 PCS (52)
A lack of sexual desire contributed to a decrease in
sexual frequency among 59% of women and 48%
of men.
IIEF= International Index of Erectile Function; SAS=Adjustment Sexual Scale; PAIS=Psychosocial Adjustment to Illness Scale; QSF= Sexual Function
Questionnaire; CESD=Center for Epidemiologic Studies, Depression Scale; HADS=Hospital Anxiety and Depression Scale; RSS=Relationship and Sexuality
Scale; ASEX=Arizona Sexual Experience Scale; FSFI = Female Sexual Function Index; BDI=Beck Depression Inventory; STAI= State-Trait Anxiety Inventory; DS-
14=Type-D Personality Scale-14; PHQ-9=9-Item Patient Health Questionnaire; and SF-12 PCS=12-Item Short-Form Health Survey, Physical Composite Score.
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revealed the presence of ED in 49% of the patients.
Specifically, these 147 patients were classified as mild (21;
14%), mild to moderate (31; 21%), moderate (20; 14%) , and
severe (75; 51%). ED occurred 38.8 months before the advent
of CAD in 99 (67%) men.
In 2005, Vacanti et al. (20) examined changes in sexual
activity six months after MI and identified variables
possibly associated with ED in 37 men (age range = 18-75
years). The results revealed 15 patients (40.5%) with ED and
9 patients with symptoms of depression. Of the 28 (89%)
patients without symptoms of depression, 7 (25%) had ED.
This study concluded that patients with MI showed a
significantly high incidence of ED. A study by Addis et al.
(21) in 2005 investigated the sexual activity of 2,763
postmenopausal women with heart disease (average
age = 67 years). SD was prevalent in 1,091 sexually active
individuals. In total, 140 (13%) reported at least one sexual
complaint (e.g., lack of interest, inability to relax, difficulty
achieving arousal or orgasm or sexual discomfort), and 570
(52%) reported two or more sexual problems.
In 2006, Shi et al. (22) investigated the incidence of SD and
the changes associated with ED among 467 men with CAD
(,70 years old). The data revealed that patients with CAD
presented ED during both the acute (p.0.05) and chronic
(p,0.05) phases of the disease. The average frequency of
sexual activity declined each month in these patients
(p,0.05 and p,0.01, respectively). Of the total sample,
58% showed a decrease in sexual frequency, 33.8% returned
to a normal sexual life, and 8.1% did not return to sexual
activity. The average time interval between the beginning of
ED and the development of CAD was 33 months. The
variables associated with ED included age, diabetes, the
occlusion of two or three coronary vessels and smoking. In
2007, Kazemi-Saleh (23) investigated the presence of sexual
fear in 87 married men with MI (average age = 59 years). The
clinical, demographic and psychological symptoms of
individuals with or without sexual fear were investigated.
The results revealed sexual fear in 29 (33.3%) men with
a lower frequency of sexual activity and symptoms of
depression.
In 2007, Eyada et al. (24) investigated the effect of cardiac
rehabilitation on the resumption of sexual activity in 35
women with angina pectoris (age range = 34-65 years). The
results revealed that 17 (48.7%) women resumed sexual
activity; however, 7 (41.2%) reported sexual dissatisfaction.
Eighteen (43%) women did not resume sexual activity,
83.3% reported a decreased sex drive, 12 (66.7%) decreased
their sexual activity, 72.2% reported symptoms of anxiety,
65% showed symptoms of depression, and 38.9% reported
sexual fears. Patients who participated in a rehabilitation
program were 3.77-fold more likely to return to sexual
activity. The following year, Lunelli et al. (26) examined
return to sexual activity after the first MI event in a sample
of 96 patients (67 men and 29 women) with an average age
of 59 years. The results revealed that 63% of patients had an
active sex life, 71% showed an interest in maintaining their
sexual activity, 60% doubted their return to sexual activity,
and 44% had reduced their sexual frequency. Only 4% were
provided information about returning to sexual activity.
This study indicated the importance of sexual education in
aiding patient return to sexual activity.
In 2008, Cook et al. (27) conducted the first study of ED in
86 young men with congenital heart disease (average age =
34 years). Patients were treated with cardiac medications,
including beta-blockers (BBs; 24%), angiotensin-converting
enzyme (ACE) inhibitors (8%), calcium-channel blockers
(CCBs; 6%) or a combination of BBs and ACE inhibitors
(16%). The results revealed ED in 87 (38%) patients. Men who
used BBs were three times more likely to have ED (p= 0.045).
Dyspnea was the cardiovascular symptom reported most
often during the sexual activity of 45 (52%) men. In 2008,
Schwarz et al. (29) investigated the prevalence of SD among
100 patients (76 men and 24 women) with CVDs during
outpatient treatment. The results revealed that 87% of women
reported arousal disorders, 84% had decreased vaginal
lubrication, 62% had difficulty reaching orgasm, 50%
reported moderate to severe sexual pain, and 29% had
reduced their sexual activity over six months. Regarding the
men, 84% had trouble maintaining an erection after penetra-
tion, 76% had reduced sexual desire and excitement, 62% had
difficulty reaching orgasm, and 31% had difficulty having an
erection for penetration.
In 2010, Lemoge et al. (31) examined the association
between ED and depressed mood among 85 men with CAD
(average age = 75 years). Significant ED was found in 57.6%
of the patients. ED was independently predicted by
depressive mood, hypertension, age (p= 0.007, p= 0.017
and p= 0.082) respectively. Kriston et al. (32) investigated
the prevalence of sexual disorders and depressive symp-
toms among 493 patients with CAD (395 men and 98
women) with an age range of 55-69 years. The results
revealed the presence of ED in 20.3% of men and SD in
43.1% of women. Moderate depressive symptoms were
present in 16.5% of men and 14.4% of women.
In 2011, Foruzan-Nia et al. (33) evaluated the incidence of
ED and SD one year before and after MI among 279 men
with an age range 25-69 years. Before MI, 6.5% of men
reported ED, 4.3% reported premature ejaculation, and 9.3%
showed a decrease in or loss of libido. The rates of SD
increased to 34.8%, 21.5% and 20.1%, respectively, 12 weeks
after MI. Finally, in 2007, Kazemi et al. (28) examined sexual
activity and psychiatric symptoms among patients with
CAD and the relationships between these variables for each
gender in 550 married patients with CAD (397 men and 153
females; average age = 57 years). The data revealed that
45.8% of women with CAD showed anxiety symptoms and
that 20.3% suffered from depression. Of the men with CAD,
16.6% reported anxiety symptoms, and 9.6% reported
depressive symptoms. A greater decrease in sexual activity
correlated with depressive symptoms in both genders.
However, fear of sexual relations correlated with depressive
symptoms only in men with CAD and their spouses
(r = 0.18, p= 0.001).
Case-Control Studies
In 1997, Abramov (14) examined aspects of the sexual
lives of 100 women aged 40-60 years after their first MI over
a three-year period compared with 100 women with other
diseases (i.e., hypertension, valvular heart disease, respira-
tory disorder, urinary tract diseases, diabetes mellitus,
gastrointestinal disease, joint diseases and allergies). The
results revealed that 50 (65%) women in the former group
reported underactive desire and sexual dissatisfaction,
whereas only 20 (24%) women in the control group did
the same. In 1999, Hultgren et al. (16) investigated the sexual
functioning of 36 women who suffered from aortoiliac
occlusive disease (AIOD). These patients were divided into
two groups: 20 women who were interviewed before
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starting medical treatment (i.e., the untreated group) and 16
who were surveyed after beginning medical treatment (i.e.,
the treated group). All participants were under 70 years old
and married. The control group was composed of 18 women
in treatment for pain or urinary tract infections, and their
age and marital status were similar to those of the
experimental groups. The results revealed that treated
patients with AIOD showed significantly impaired physical
wellbeing compared with the other groups (p,0.001).
Vascular disease had a negative effect on the sexual
functioning of 11 (69%) patients in the treated group
compared with only 8 (40%) in the untreated group. A lack
of vaginal lubrication during sexual intercourse was
reported by 7 (64%) women in the untreated group, 5
(45%) in the treated group and 4 (25%) in the control group.
Orgasm disorders were found in 6 (43%) women in the
untreated group, 4 (31%) in the treated group and 4 (25%) in
the control group. Vulvar sensitivity was impaired in 7
(44%) women in the treated group, 2 (11%) women in the
untreated group and 4 (22%) control patients. Finally, in
2007, Kaya et al. (25) investigated the sexual functioning of
20 women with CAD (average age = 38 years) and 15
healthy subjects. The patients with CAD and the healthy
women were comparable in age, body mass index and
education level. The results revealed SD in 12 (60%) women
with CAD compared with 15 (33.3%) women in the control
group. All Female Sexual Function Index (FSFI) domain
scores, except satisfaction, were lower in the group with
CAD compared with the healthy participants (p,0.05). This
preliminary study demonstrated that female patients with
CAD had a high prevalence of SD compared with healthy
controls.
Randomized Clinical Trials
In 2010, Hoffman et al. (30) investigated the association
between CVD risk factors and vascular endothelial function
among 46 men (average age = 53 years) with major
depressive disorder. The results indicated that ED was not
associated with depression severity (r = 0.00, p= 0.09). In
contrast, greater ED was associated with higher CVD risk
(r = 0.42, p= 0.004), and age was strongly associated with ED
(r = 0.43, p= 0.003). ED was associated with greater CVD risk
and impaired vascular endothelial function in depressed
men.
& DISCUSSION
The current review indicates that a high prevalence of SD
exists among men and women with CVDs. Physiological
changes in sexual satisfaction, such as ED in men and sexual
arousal in women, were correlated with CAD severity. In
certain studies (11,13,19,22,29), men with severe CAD (i.e.,
two or more occluded coronary vessels) had the most
difficulty attaining and maintaining penile erection com-
pared with men with only one coronary vessel occlusion. In
other individuals, SD was related to desire, arousal, orgasm
and ejaculation. This dysfunction is due to peripheral artery
disease and CAD, for which atherosclerosis is a common
risk factor. This disease is responsible for the formation of
fatty plaques that narrow the arteries. Hence, an insufficient
amount of blood flows to the body, including through the
small arteries that irrigate the genital tissues of men and
women (5-6). ED affects the muscles of the penis and
associated fibrous tissue, which alters sexual arousal and
orgasm because of reduced penile rigidity, erection time
and ejaculation (53). The literature has demonstrated that
ED affects 46% of men with CAD; of these men, 75% present
problems achieving erections, and 67% have problems
maintaining erections (54).
Similar to male erections, female genital arousal is
achieved when the vascular system increases blood flow
to the labia via vasodilatation, which is accompanied by
vaginal lubrication and clitoral erection (3). Certain studies
(16-17,24-25,27,32) have revealed an effect of CVD on
women’s sexual desire; arousal dysfunction, with decreased
sensitivity of the clitoris and vaginal labia; and orgasm.
Certain women with heart failure present problems with
vaginal lubrication before and during sexual intercourse,
and many report moderate to severe sexual pain (29).
In addition, the frequency of ED increases with the use of
BBs in men (27). Cardiovascular medications often have
sexual side effects that can affect male erections and sexual
desire (55). This study did not include a bibliographic
review paper concerning the effects of cardiovascular drugs
on female SD.
In certain studies (20,31,32), age and depressive symp-
toms predicted SD in male and female patients. The free
testosterone levels of humans decrease almost yearly
between the ages of 40 and 70 years, resulting in a serious
testosterone decline of 0.4 per year (3). Decreases in
testosterone can diminish the erectile response, satisfaction
and sexual frequency (17). In women, this process occurs
during menopause and can cause various sexual problems
(21). Depression is an important risk factor for SD, as this
condition may compromise sexual desire, and unsatisfying
sexual performance is related to depression (20,23,24,28). In
the absence of sexual desire, sexual fantasies are rare or
fleeting sexual stimuli and may not occur efficiently,
preventing completion of the sexual response cycle (2).
Depressive symptoms have different effects on the emer-
gence of SD. Antidepressant drugs affect penile erection,
sexual arousal and vaginal lubrication (2). The biological
mechanism related to depression can reduce the ability to
relax the smooth muscles of erectile tissue. Depressive
symptoms might reduce erotic focus and the psychogenic
stimulus, thereby impairing the sexual response cycle (8,20).
Importantly, a randomized clinical review study (30) did
not find an association between depression severity and ED
in men with CVDs. The authors indicated that depression
might influence ED but that depression does not contribute
to ED.
In certain studies (11,7,20,22,34), patients showed reduced
sexual desire, less sexual satisfaction and ED after MI. CVDs
can alter sexual desire because the physical and psycholo-
gical manifestations of a medical illness can decrease sexual
interest (10).
One study (20) in this review reported the existence of a
literature-based estimate that 58% of patients recovering
from CVD have psychological problems. Heart disease
and depression are very common, frequently concomitant
conditions that were previously speculated by the World
Health Organization to be the first and second leading
causes, respectively, of disability. Depressive symptoms can
occur when individuals remain hospitalized and persist
throughout the recovery period in addition to affecting
patients’ energy levels and the time needed to return to
sexual activity (56). One study reported that after a cardiac
event, 25% of patients returned to a normal sexual life, 50%
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showed a decrease in sexual activity, and 25% did not return
to sexual activity (9).
Fear of sexual intercourse, a mental factor in the context
of CAD, is comorbid with decreased desire, satisfaction
and sexual frequency among male and female patients
(23,24,28). After the onset of CVD, SD might be due to
apprehension regarding sexual activity. Patients consider
the physical exertion of intercourse to be harmful and
dangerous to their hearts and fear sudden death during sex.
These fears significantly contribute to the decline in sexual
frequency and consequently delay the resumption of sexual
activity.
CVDs contribute to changes in the sexual response cycles
of a patient. Certain studies (24,26,34) indicated the
importance of sexual education offered by health profes-
sionals for returning patients to sexual activity and possibly
reducing the onset of the SD that affects these individuals
(33).
In conclusion, CVDs are risk factors for the emergence of
SD. The severity of heart disease increases the occurrence of
SD. In addition, symptoms of depression associated with
CVD and SD, which emerge during the recovery of patients
with heart disease, marked by physical and psychological
adaptations, contribute to the impairment of sexual
responses. Therefore, SD can occur following the develop-
ment of CVD.
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